Skip to main content

Allopurinol

NDC 59651-285 · Aurobindo Pharma Limited

Generic nameAllopurinol
Dosage formTABLET
RouteORAL
Active ingredient(s)ALLOPURINOL
Strength100 mg/1
Pharmacologic classXanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
Marketing categoryANDA

Packages

59651-285-01 — 100 TABLET in 1 BOTTLE (59651-285-01)

59651-285-99 — 1000 TABLET in 1 BOTTLE (59651-285-99)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

53401-025 — ALLOPURINOL, 53489-156 — Allopurinol, 53489-157 — Allopurinol, 55111-729 — allopurinol, 55111-730 — allopurinol, 55154-0282 — allopurinol, 55154-2338 — Allopurinol, 55154-5454 — Allopurinol, 55154-5534 — Allopurinol, 55154-7981 — allopurinol, 59651-286 — Allopurinol, 60687-677 — Allopurinol, 60687-688 — Allopurinol, 60760-656 — Allopurinol, 60760-710 — Allopurinol, 60760-722 — Allopurinol, 60760-989 — Allopurinol, 62135-516 — Allopurinol, 62135-517 — Allopurinol, 63187-240 — Allopurinol, +142 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T50.4X1 — Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), T50.4X2 — Poisoning by drugs affecting uric acid metabolism, intentional self-harm, T50.4X3 — Poisoning by drugs affecting uric acid metabolism, assault, T50.4X4 — Poisoning by drugs affecting uric acid metabolism, undetermined, T50.4X5 — Adverse effect of drugs affecting uric acid metabolism, T50.4X6 — Underdosing of drugs affecting uric acid metabolism